Global Generic Medicine Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Generic Medicine Industry Forecast” looks at past sales and reviews total world Generic Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Generic Medicine sales for 2023 through 2029. With Generic Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Medicine industry.
This Insight Report provides a comprehensive analysis of the global Generic Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Generic Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Medicine.
The global Generic Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Generic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Generic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Generic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Generic Medicine players cover Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi and Aurobindo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Generic Medicine Industry Forecast” looks at past sales and reviews total world Generic Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Generic Medicine sales for 2023 through 2029. With Generic Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Generic Medicine industry.
This Insight Report provides a comprehensive analysis of the global Generic Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Generic Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Generic Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Generic Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Generic Medicine.
The global Generic Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Generic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Generic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Generic Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Generic Medicine players cover Teva, Novartis - Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi and Aurobindo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Generic Medicine market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Simple Generic Drugs
- Super Generic Drugs
- Biosimilars
- By Application:
- CNS
- Cardiovascular
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- CNS
- Cardiovascular
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Novartis - Sandoz
- Mylan
- Sun Pharmaceutical
- Aspen
- Fresenius Kabi
- Pfizer (Hospira)
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy's
- Apotex
- Cipla
- ENDO (Par Pharmaceutical)
- Stada Arzneimittel
- Krka Group
- Nichi-Iko Pharmaceutical
- Valeant
- Zydus Cadila
- Hikma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Generic Medicine Market Size 2018-2029
2.1.2 Generic Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Generic Medicine Segment by Type
2.2.1 Simple Generic Drugs
2.2.2 Super Generic Drugs
2.2.3 Biosimilars
2.2.4 By Application:
2.2.5 CNS
2.2.6 Cardiovascular
2.2.7 Respiratory
2.2.8 Rheumatology
2.2.9 Diabetes
2.2.10 Oncology
2.3 Generic Medicine Market Size by Type
2.3.1 Generic Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Generic Medicine Market Size Market Share by Type (2018-2023)
2.4 Generic Medicine Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Respiratory
2.4.4 Rheumatology
2.4.5 Diabetes
2.4.6 Oncology
2.4.7 Others
2.5 Generic Medicine Market Size by Application
2.5.1 Generic Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Generic Medicine Market Size Market Share by Application (2018-2023)
3 GENERIC MEDICINE MARKET SIZE BY PLAYER
3.1 Generic Medicine Market Size Market Share by Players
3.1.1 Global Generic Medicine Revenue by Players (2018-2023)
3.1.2 Global Generic Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Generic Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENERIC MEDICINE BY REGIONS
4.1 Generic Medicine Market Size by Regions (2018-2023)
4.2 Americas Generic Medicine Market Size Growth (2018-2023)
4.3 APAC Generic Medicine Market Size Growth (2018-2023)
4.4 Europe Generic Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Generic Medicine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Generic Medicine Market Size by Country (2018-2023)
5.2 Americas Generic Medicine Market Size by Type (2018-2023)
5.3 Americas Generic Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Medicine Market Size by Region (2018-2023)
6.2 APAC Generic Medicine Market Size by Type (2018-2023)
6.3 APAC Generic Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Generic Medicine by Country (2018-2023)
7.2 Europe Generic Medicine Market Size by Type (2018-2023)
7.3 Europe Generic Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Generic Medicine by Region (2018-2023)
8.2 Middle East & Africa Generic Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Generic Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENERIC MEDICINE MARKET FORECAST
10.1 Global Generic Medicine Forecast by Regions (2024-2029)
10.1.1 Global Generic Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Generic Medicine Forecast
10.1.3 APAC Generic Medicine Forecast
10.1.4 Europe Generic Medicine Forecast
10.1.5 Middle East & Africa Generic Medicine Forecast
10.2 Americas Generic Medicine Forecast by Country (2024-2029)
10.2.1 United States Generic Medicine Market Forecast
10.2.2 Canada Generic Medicine Market Forecast
10.2.3 Mexico Generic Medicine Market Forecast
10.2.4 Brazil Generic Medicine Market Forecast
10.3 APAC Generic Medicine Forecast by Region (2024-2029)
10.3.1 China Generic Medicine Market Forecast
10.3.2 Japan Generic Medicine Market Forecast
10.3.3 Korea Generic Medicine Market Forecast
10.3.4 Southeast Asia Generic Medicine Market Forecast
10.3.5 India Generic Medicine Market Forecast
10.3.6 Australia Generic Medicine Market Forecast
10.4 Europe Generic Medicine Forecast by Country (2024-2029)
10.4.1 Germany Generic Medicine Market Forecast
10.4.2 France Generic Medicine Market Forecast
10.4.3 UK Generic Medicine Market Forecast
10.4.4 Italy Generic Medicine Market Forecast
10.4.5 Russia Generic Medicine Market Forecast
10.5 Middle East & Africa Generic Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Generic Medicine Market Forecast
10.5.2 South Africa Generic Medicine Market Forecast
10.5.3 Israel Generic Medicine Market Forecast
10.5.4 Turkey Generic Medicine Market Forecast
10.5.5 GCC Countries Generic Medicine Market Forecast
10.6 Global Generic Medicine Forecast by Type (2024-2029)
10.7 Global Generic Medicine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Medicine Product Offered
11.1.3 Teva Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Information
11.2.2 Novartis - Sandoz Generic Medicine Product Offered
11.2.3 Novartis - Sandoz Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis - Sandoz Main Business Overview
11.2.5 Novartis - Sandoz Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Generic Medicine Product Offered
11.3.3 Mylan Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Medicine Product Offered
11.4.3 Sun Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen
11.5.1 Aspen Company Information
11.5.2 Aspen Generic Medicine Product Offered
11.5.3 Aspen Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Aspen Main Business Overview
11.5.5 Aspen Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Medicine Product Offered
11.6.3 Fresenius Kabi Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Information
11.7.2 Pfizer (Hospira) Generic Medicine Product Offered
11.7.3 Pfizer (Hospira) Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer (Hospira) Main Business Overview
11.7.5 Pfizer (Hospira) Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Generic Medicine Product Offered
11.8.3 Sanofi Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Aurobindo
11.9.1 Aurobindo Company Information
11.9.2 Aurobindo Generic Medicine Product Offered
11.9.3 Aurobindo Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Aurobindo Main Business Overview
11.9.5 Aurobindo Latest Developments
11.10 Lupin
11.10.1 Lupin Company Information
11.10.2 Lupin Generic Medicine Product Offered
11.10.3 Lupin Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Lupin Main Business Overview
11.10.5 Lupin Latest Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Information
11.11.2 Dr. Reddy's Generic Medicine Product Offered
11.11.3 Dr. Reddy's Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Dr. Reddy's Main Business Overview
11.11.5 Dr. Reddy's Latest Developments
11.12 Apotex
11.12.1 Apotex Company Information
11.12.2 Apotex Generic Medicine Product Offered
11.12.3 Apotex Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Apotex Main Business Overview
11.12.5 Apotex Latest Developments
11.13 Cipla
11.13.1 Cipla Company Information
11.13.2 Cipla Generic Medicine Product Offered
11.13.3 Cipla Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Cipla Main Business Overview
11.13.5 Cipla Latest Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Information
11.14.2 ENDO (Par Pharmaceutical) Generic Medicine Product Offered
11.14.3 ENDO (Par Pharmaceutical) Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 ENDO (Par Pharmaceutical) Main Business Overview
11.14.5 ENDO (Par Pharmaceutical) Latest Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Information
11.15.2 Stada Arzneimittel Generic Medicine Product Offered
11.15.3 Stada Arzneimittel Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Stada Arzneimittel Main Business Overview
11.15.5 Stada Arzneimittel Latest Developments
11.16 Krka Group
11.16.1 Krka Group Company Information
11.16.2 Krka Group Generic Medicine Product Offered
11.16.3 Krka Group Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Krka Group Main Business Overview
11.16.5 Krka Group Latest Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Information
11.17.2 Nichi-Iko Pharmaceutical Generic Medicine Product Offered
11.17.3 Nichi-Iko Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Nichi-Iko Pharmaceutical Main Business Overview
11.17.5 Nichi-Iko Pharmaceutical Latest Developments
11.18 Valeant
11.18.1 Valeant Company Information
11.18.2 Valeant Generic Medicine Product Offered
11.18.3 Valeant Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Valeant Main Business Overview
11.18.5 Valeant Latest Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Information
11.19.2 Zydus Cadila Generic Medicine Product Offered
11.19.3 Zydus Cadila Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Zydus Cadila Main Business Overview
11.19.5 Zydus Cadila Latest Developments
11.20 Hikma
11.20.1 Hikma Company Information
11.20.2 Hikma Generic Medicine Product Offered
11.20.3 Hikma Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Hikma Main Business Overview
11.20.5 Hikma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Generic Medicine Market Size 2018-2029
2.1.2 Generic Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Generic Medicine Segment by Type
2.2.1 Simple Generic Drugs
2.2.2 Super Generic Drugs
2.2.3 Biosimilars
2.2.4 By Application:
2.2.5 CNS
2.2.6 Cardiovascular
2.2.7 Respiratory
2.2.8 Rheumatology
2.2.9 Diabetes
2.2.10 Oncology
2.3 Generic Medicine Market Size by Type
2.3.1 Generic Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Generic Medicine Market Size Market Share by Type (2018-2023)
2.4 Generic Medicine Segment by Application
2.4.1 CNS
2.4.2 Cardiovascular
2.4.3 Respiratory
2.4.4 Rheumatology
2.4.5 Diabetes
2.4.6 Oncology
2.4.7 Others
2.5 Generic Medicine Market Size by Application
2.5.1 Generic Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Generic Medicine Market Size Market Share by Application (2018-2023)
3 GENERIC MEDICINE MARKET SIZE BY PLAYER
3.1 Generic Medicine Market Size Market Share by Players
3.1.1 Global Generic Medicine Revenue by Players (2018-2023)
3.1.2 Global Generic Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Generic Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENERIC MEDICINE BY REGIONS
4.1 Generic Medicine Market Size by Regions (2018-2023)
4.2 Americas Generic Medicine Market Size Growth (2018-2023)
4.3 APAC Generic Medicine Market Size Growth (2018-2023)
4.4 Europe Generic Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa Generic Medicine Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Generic Medicine Market Size by Country (2018-2023)
5.2 Americas Generic Medicine Market Size by Type (2018-2023)
5.3 Americas Generic Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Generic Medicine Market Size by Region (2018-2023)
6.2 APAC Generic Medicine Market Size by Type (2018-2023)
6.3 APAC Generic Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Generic Medicine by Country (2018-2023)
7.2 Europe Generic Medicine Market Size by Type (2018-2023)
7.3 Europe Generic Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Generic Medicine by Region (2018-2023)
8.2 Middle East & Africa Generic Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa Generic Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENERIC MEDICINE MARKET FORECAST
10.1 Global Generic Medicine Forecast by Regions (2024-2029)
10.1.1 Global Generic Medicine Forecast by Regions (2024-2029)
10.1.2 Americas Generic Medicine Forecast
10.1.3 APAC Generic Medicine Forecast
10.1.4 Europe Generic Medicine Forecast
10.1.5 Middle East & Africa Generic Medicine Forecast
10.2 Americas Generic Medicine Forecast by Country (2024-2029)
10.2.1 United States Generic Medicine Market Forecast
10.2.2 Canada Generic Medicine Market Forecast
10.2.3 Mexico Generic Medicine Market Forecast
10.2.4 Brazil Generic Medicine Market Forecast
10.3 APAC Generic Medicine Forecast by Region (2024-2029)
10.3.1 China Generic Medicine Market Forecast
10.3.2 Japan Generic Medicine Market Forecast
10.3.3 Korea Generic Medicine Market Forecast
10.3.4 Southeast Asia Generic Medicine Market Forecast
10.3.5 India Generic Medicine Market Forecast
10.3.6 Australia Generic Medicine Market Forecast
10.4 Europe Generic Medicine Forecast by Country (2024-2029)
10.4.1 Germany Generic Medicine Market Forecast
10.4.2 France Generic Medicine Market Forecast
10.4.3 UK Generic Medicine Market Forecast
10.4.4 Italy Generic Medicine Market Forecast
10.4.5 Russia Generic Medicine Market Forecast
10.5 Middle East & Africa Generic Medicine Forecast by Region (2024-2029)
10.5.1 Egypt Generic Medicine Market Forecast
10.5.2 South Africa Generic Medicine Market Forecast
10.5.3 Israel Generic Medicine Market Forecast
10.5.4 Turkey Generic Medicine Market Forecast
10.5.5 GCC Countries Generic Medicine Market Forecast
10.6 Global Generic Medicine Forecast by Type (2024-2029)
10.7 Global Generic Medicine Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Generic Medicine Product Offered
11.1.3 Teva Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis - Sandoz
11.2.1 Novartis - Sandoz Company Information
11.2.2 Novartis - Sandoz Generic Medicine Product Offered
11.2.3 Novartis - Sandoz Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis - Sandoz Main Business Overview
11.2.5 Novartis - Sandoz Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Generic Medicine Product Offered
11.3.3 Mylan Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Information
11.4.2 Sun Pharmaceutical Generic Medicine Product Offered
11.4.3 Sun Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sun Pharmaceutical Main Business Overview
11.4.5 Sun Pharmaceutical Latest Developments
11.5 Aspen
11.5.1 Aspen Company Information
11.5.2 Aspen Generic Medicine Product Offered
11.5.3 Aspen Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Aspen Main Business Overview
11.5.5 Aspen Latest Developments
11.6 Fresenius Kabi
11.6.1 Fresenius Kabi Company Information
11.6.2 Fresenius Kabi Generic Medicine Product Offered
11.6.3 Fresenius Kabi Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Fresenius Kabi Main Business Overview
11.6.5 Fresenius Kabi Latest Developments
11.7 Pfizer (Hospira)
11.7.1 Pfizer (Hospira) Company Information
11.7.2 Pfizer (Hospira) Generic Medicine Product Offered
11.7.3 Pfizer (Hospira) Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Pfizer (Hospira) Main Business Overview
11.7.5 Pfizer (Hospira) Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Generic Medicine Product Offered
11.8.3 Sanofi Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Aurobindo
11.9.1 Aurobindo Company Information
11.9.2 Aurobindo Generic Medicine Product Offered
11.9.3 Aurobindo Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Aurobindo Main Business Overview
11.9.5 Aurobindo Latest Developments
11.10 Lupin
11.10.1 Lupin Company Information
11.10.2 Lupin Generic Medicine Product Offered
11.10.3 Lupin Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Lupin Main Business Overview
11.10.5 Lupin Latest Developments
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Information
11.11.2 Dr. Reddy's Generic Medicine Product Offered
11.11.3 Dr. Reddy's Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Dr. Reddy's Main Business Overview
11.11.5 Dr. Reddy's Latest Developments
11.12 Apotex
11.12.1 Apotex Company Information
11.12.2 Apotex Generic Medicine Product Offered
11.12.3 Apotex Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Apotex Main Business Overview
11.12.5 Apotex Latest Developments
11.13 Cipla
11.13.1 Cipla Company Information
11.13.2 Cipla Generic Medicine Product Offered
11.13.3 Cipla Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Cipla Main Business Overview
11.13.5 Cipla Latest Developments
11.14 ENDO (Par Pharmaceutical)
11.14.1 ENDO (Par Pharmaceutical) Company Information
11.14.2 ENDO (Par Pharmaceutical) Generic Medicine Product Offered
11.14.3 ENDO (Par Pharmaceutical) Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 ENDO (Par Pharmaceutical) Main Business Overview
11.14.5 ENDO (Par Pharmaceutical) Latest Developments
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Information
11.15.2 Stada Arzneimittel Generic Medicine Product Offered
11.15.3 Stada Arzneimittel Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Stada Arzneimittel Main Business Overview
11.15.5 Stada Arzneimittel Latest Developments
11.16 Krka Group
11.16.1 Krka Group Company Information
11.16.2 Krka Group Generic Medicine Product Offered
11.16.3 Krka Group Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Krka Group Main Business Overview
11.16.5 Krka Group Latest Developments
11.17 Nichi-Iko Pharmaceutical
11.17.1 Nichi-Iko Pharmaceutical Company Information
11.17.2 Nichi-Iko Pharmaceutical Generic Medicine Product Offered
11.17.3 Nichi-Iko Pharmaceutical Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Nichi-Iko Pharmaceutical Main Business Overview
11.17.5 Nichi-Iko Pharmaceutical Latest Developments
11.18 Valeant
11.18.1 Valeant Company Information
11.18.2 Valeant Generic Medicine Product Offered
11.18.3 Valeant Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Valeant Main Business Overview
11.18.5 Valeant Latest Developments
11.19 Zydus Cadila
11.19.1 Zydus Cadila Company Information
11.19.2 Zydus Cadila Generic Medicine Product Offered
11.19.3 Zydus Cadila Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Zydus Cadila Main Business Overview
11.19.5 Zydus Cadila Latest Developments
11.20 Hikma
11.20.1 Hikma Company Information
11.20.2 Hikma Generic Medicine Product Offered
11.20.3 Hikma Generic Medicine Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Hikma Main Business Overview
11.20.5 Hikma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Generic Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Simple Generic Drugs
Table 3. Major Players of Super Generic Drugs
Table 4. Major Players of Biosimilars
Table 5. Major Players of By Application:
Table 6. Major Players of CNS
Table 7. Major Players of Cardiovascular
Table 8. Major Players of Respiratory
Table 9. Major Players of Rheumatology
Table 10. Major Players of Diabetes
Table 11. Major Players of Oncology
Table 12. Generic Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 14. Global Generic Medicine Market Size Market Share by Type (2018-2023)
Table 15. Generic Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 16. Global Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 17. Global Generic Medicine Market Size Market Share by Application (2018-2023)
Table 18. Global Generic Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 19. Global Generic Medicine Revenue Market Share by Player (2018-2023)
Table 20. Generic Medicine Key Players Head office and Products Offered
Table 21. Generic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Generic Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 25. Global Generic Medicine Market Size Market Share by Regions (2018-2023)
Table 26. Global Generic Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 27. Global Generic Medicine Revenue Market Share by Country/Region (2018-2023)
Table 28. Americas Generic Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 29. Americas Generic Medicine Market Size Market Share by Country (2018-2023)
Table 30. Americas Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 31. Americas Generic Medicine Market Size Market Share by Type (2018-2023)
Table 32. Americas Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 33. Americas Generic Medicine Market Size Market Share by Application (2018-2023)
Table 34. APAC Generic Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 35. APAC Generic Medicine Market Size Market Share by Region (2018-2023)
Table 36. APAC Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 37. APAC Generic Medicine Market Size Market Share by Type (2018-2023)
Table 38. APAC Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 39. APAC Generic Medicine Market Size Market Share by Application (2018-2023)
Table 40. Europe Generic Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 41. Europe Generic Medicine Market Size Market Share by Country (2018-2023)
Table 42. Europe Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 43. Europe Generic Medicine Market Size Market Share by Type (2018-2023)
Table 44. Europe Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 45. Europe Generic Medicine Market Size Market Share by Application (2018-2023)
Table 46. Middle East & Africa Generic Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Generic Medicine Market Size Market Share by Region (2018-2023)
Table 48. Middle East & Africa Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 49. Middle East & Africa Generic Medicine Market Size Market Share by Type (2018-2023)
Table 50. Middle East & Africa Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 51. Middle East & Africa Generic Medicine Market Size Market Share by Application (2018-2023)
Table 52. Key Market Drivers & Growth Opportunities of Generic Medicine
Table 53. Key Market Challenges & Risks of Generic Medicine
Table 54. Key Industry Trends of Generic Medicine
Table 55. Global Generic Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 56. Global Generic Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 57. Global Generic Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 58. Global Generic Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 59. Teva Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 60. Teva Generic Medicine Product Offered
Table 61. Teva Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Teva Main Business
Table 63. Teva Latest Developments
Table 64. Novartis - Sandoz Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 65. Novartis - Sandoz Generic Medicine Product Offered
Table 66. Novartis - Sandoz Main Business
Table 67. Novartis - Sandoz Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Novartis - Sandoz Latest Developments
Table 69. Mylan Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 70. Mylan Generic Medicine Product Offered
Table 71. Mylan Main Business
Table 72. Mylan Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Mylan Latest Developments
Table 74. Sun Pharmaceutical Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 75. Sun Pharmaceutical Generic Medicine Product Offered
Table 76. Sun Pharmaceutical Main Business
Table 77. Sun Pharmaceutical Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Sun Pharmaceutical Latest Developments
Table 79. Aspen Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 80. Aspen Generic Medicine Product Offered
Table 81. Aspen Main Business
Table 82. Aspen Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Aspen Latest Developments
Table 84. Fresenius Kabi Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 85. Fresenius Kabi Generic Medicine Product Offered
Table 86. Fresenius Kabi Main Business
Table 87. Fresenius Kabi Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Fresenius Kabi Latest Developments
Table 89. Pfizer (Hospira) Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 90. Pfizer (Hospira) Generic Medicine Product Offered
Table 91. Pfizer (Hospira) Main Business
Table 92. Pfizer (Hospira) Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Pfizer (Hospira) Latest Developments
Table 94. Sanofi Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 95. Sanofi Generic Medicine Product Offered
Table 96. Sanofi Main Business
Table 97. Sanofi Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Sanofi Latest Developments
Table 99. Aurobindo Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 100. Aurobindo Generic Medicine Product Offered
Table 101. Aurobindo Main Business
Table 102. Aurobindo Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Aurobindo Latest Developments
Table 104. Lupin Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 105. Lupin Generic Medicine Product Offered
Table 106. Lupin Main Business
Table 107. Lupin Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 108. Lupin Latest Developments
Table 109. Dr. Reddy's Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 110. Dr. Reddy's Generic Medicine Product Offered
Table 111. Dr. Reddy's Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Dr. Reddy's Main Business
Table 113. Dr. Reddy's Latest Developments
Table 114. Apotex Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 115. Apotex Generic Medicine Product Offered
Table 116. Apotex Main Business
Table 117. Apotex Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Apotex Latest Developments
Table 119. Cipla Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 120. Cipla Generic Medicine Product Offered
Table 121. Cipla Main Business
Table 122. Cipla Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Cipla Latest Developments
Table 124. ENDO (Par Pharmaceutical) Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 125. ENDO (Par Pharmaceutical) Generic Medicine Product Offered
Table 126. ENDO (Par Pharmaceutical) Main Business
Table 127. ENDO (Par Pharmaceutical) Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. ENDO (Par Pharmaceutical) Latest Developments
Table 129. Stada Arzneimittel Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 130. Stada Arzneimittel Generic Medicine Product Offered
Table 131. Stada Arzneimittel Main Business
Table 132. Stada Arzneimittel Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. Stada Arzneimittel Latest Developments
Table 134. Krka Group Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 135. Krka Group Generic Medicine Product Offered
Table 136. Krka Group Main Business
Table 137. Krka Group Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. Krka Group Latest Developments
Table 139. Nichi-Iko Pharmaceutical Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 140. Nichi-Iko Pharmaceutical Generic Medicine Product Offered
Table 141. Nichi-Iko Pharmaceutical Main Business
Table 142. Nichi-Iko Pharmaceutical Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 143. Nichi-Iko Pharmaceutical Latest Developments
Table 144. Valeant Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 145. Valeant Generic Medicine Product Offered
Table 146. Valeant Main Business
Table 147. Valeant Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 148. Valeant Latest Developments
Table 149. Zydus Cadila Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 150. Zydus Cadila Generic Medicine Product Offered
Table 151. Zydus Cadila Main Business
Table 152. Zydus Cadila Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 153. Zydus Cadila Latest Developments
Table 154. Hikma Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 155. Hikma Generic Medicine Product Offered
Table 156. Hikma Main Business
Table 157. Hikma Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 158. Hikma Latest Developments
Table 1. Generic Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Simple Generic Drugs
Table 3. Major Players of Super Generic Drugs
Table 4. Major Players of Biosimilars
Table 5. Major Players of By Application:
Table 6. Major Players of CNS
Table 7. Major Players of Cardiovascular
Table 8. Major Players of Respiratory
Table 9. Major Players of Rheumatology
Table 10. Major Players of Diabetes
Table 11. Major Players of Oncology
Table 12. Generic Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 14. Global Generic Medicine Market Size Market Share by Type (2018-2023)
Table 15. Generic Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 16. Global Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 17. Global Generic Medicine Market Size Market Share by Application (2018-2023)
Table 18. Global Generic Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 19. Global Generic Medicine Revenue Market Share by Player (2018-2023)
Table 20. Generic Medicine Key Players Head office and Products Offered
Table 21. Generic Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Generic Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 25. Global Generic Medicine Market Size Market Share by Regions (2018-2023)
Table 26. Global Generic Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 27. Global Generic Medicine Revenue Market Share by Country/Region (2018-2023)
Table 28. Americas Generic Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 29. Americas Generic Medicine Market Size Market Share by Country (2018-2023)
Table 30. Americas Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 31. Americas Generic Medicine Market Size Market Share by Type (2018-2023)
Table 32. Americas Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 33. Americas Generic Medicine Market Size Market Share by Application (2018-2023)
Table 34. APAC Generic Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 35. APAC Generic Medicine Market Size Market Share by Region (2018-2023)
Table 36. APAC Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 37. APAC Generic Medicine Market Size Market Share by Type (2018-2023)
Table 38. APAC Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 39. APAC Generic Medicine Market Size Market Share by Application (2018-2023)
Table 40. Europe Generic Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 41. Europe Generic Medicine Market Size Market Share by Country (2018-2023)
Table 42. Europe Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 43. Europe Generic Medicine Market Size Market Share by Type (2018-2023)
Table 44. Europe Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 45. Europe Generic Medicine Market Size Market Share by Application (2018-2023)
Table 46. Middle East & Africa Generic Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Generic Medicine Market Size Market Share by Region (2018-2023)
Table 48. Middle East & Africa Generic Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 49. Middle East & Africa Generic Medicine Market Size Market Share by Type (2018-2023)
Table 50. Middle East & Africa Generic Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 51. Middle East & Africa Generic Medicine Market Size Market Share by Application (2018-2023)
Table 52. Key Market Drivers & Growth Opportunities of Generic Medicine
Table 53. Key Market Challenges & Risks of Generic Medicine
Table 54. Key Industry Trends of Generic Medicine
Table 55. Global Generic Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 56. Global Generic Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 57. Global Generic Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 58. Global Generic Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 59. Teva Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 60. Teva Generic Medicine Product Offered
Table 61. Teva Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Teva Main Business
Table 63. Teva Latest Developments
Table 64. Novartis - Sandoz Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 65. Novartis - Sandoz Generic Medicine Product Offered
Table 66. Novartis - Sandoz Main Business
Table 67. Novartis - Sandoz Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Novartis - Sandoz Latest Developments
Table 69. Mylan Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 70. Mylan Generic Medicine Product Offered
Table 71. Mylan Main Business
Table 72. Mylan Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. Mylan Latest Developments
Table 74. Sun Pharmaceutical Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 75. Sun Pharmaceutical Generic Medicine Product Offered
Table 76. Sun Pharmaceutical Main Business
Table 77. Sun Pharmaceutical Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Sun Pharmaceutical Latest Developments
Table 79. Aspen Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 80. Aspen Generic Medicine Product Offered
Table 81. Aspen Main Business
Table 82. Aspen Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Aspen Latest Developments
Table 84. Fresenius Kabi Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 85. Fresenius Kabi Generic Medicine Product Offered
Table 86. Fresenius Kabi Main Business
Table 87. Fresenius Kabi Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Fresenius Kabi Latest Developments
Table 89. Pfizer (Hospira) Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 90. Pfizer (Hospira) Generic Medicine Product Offered
Table 91. Pfizer (Hospira) Main Business
Table 92. Pfizer (Hospira) Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Pfizer (Hospira) Latest Developments
Table 94. Sanofi Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 95. Sanofi Generic Medicine Product Offered
Table 96. Sanofi Main Business
Table 97. Sanofi Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Sanofi Latest Developments
Table 99. Aurobindo Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 100. Aurobindo Generic Medicine Product Offered
Table 101. Aurobindo Main Business
Table 102. Aurobindo Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Aurobindo Latest Developments
Table 104. Lupin Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 105. Lupin Generic Medicine Product Offered
Table 106. Lupin Main Business
Table 107. Lupin Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 108. Lupin Latest Developments
Table 109. Dr. Reddy's Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 110. Dr. Reddy's Generic Medicine Product Offered
Table 111. Dr. Reddy's Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. Dr. Reddy's Main Business
Table 113. Dr. Reddy's Latest Developments
Table 114. Apotex Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 115. Apotex Generic Medicine Product Offered
Table 116. Apotex Main Business
Table 117. Apotex Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Apotex Latest Developments
Table 119. Cipla Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 120. Cipla Generic Medicine Product Offered
Table 121. Cipla Main Business
Table 122. Cipla Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Cipla Latest Developments
Table 124. ENDO (Par Pharmaceutical) Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 125. ENDO (Par Pharmaceutical) Generic Medicine Product Offered
Table 126. ENDO (Par Pharmaceutical) Main Business
Table 127. ENDO (Par Pharmaceutical) Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. ENDO (Par Pharmaceutical) Latest Developments
Table 129. Stada Arzneimittel Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 130. Stada Arzneimittel Generic Medicine Product Offered
Table 131. Stada Arzneimittel Main Business
Table 132. Stada Arzneimittel Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. Stada Arzneimittel Latest Developments
Table 134. Krka Group Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 135. Krka Group Generic Medicine Product Offered
Table 136. Krka Group Main Business
Table 137. Krka Group Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. Krka Group Latest Developments
Table 139. Nichi-Iko Pharmaceutical Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 140. Nichi-Iko Pharmaceutical Generic Medicine Product Offered
Table 141. Nichi-Iko Pharmaceutical Main Business
Table 142. Nichi-Iko Pharmaceutical Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 143. Nichi-Iko Pharmaceutical Latest Developments
Table 144. Valeant Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 145. Valeant Generic Medicine Product Offered
Table 146. Valeant Main Business
Table 147. Valeant Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 148. Valeant Latest Developments
Table 149. Zydus Cadila Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 150. Zydus Cadila Generic Medicine Product Offered
Table 151. Zydus Cadila Main Business
Table 152. Zydus Cadila Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 153. Zydus Cadila Latest Developments
Table 154. Hikma Details, Company Type, Generic Medicine Area Served and Its Competitors
Table 155. Hikma Generic Medicine Product Offered
Table 156. Hikma Main Business
Table 157. Hikma Generic Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 158. Hikma Latest Developments
LIST OF FIGURES
Figure 1. Generic Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Generic Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Generic Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Generic Medicine Sales Market Share by Country/Region (2022)
Figure 8. Generic Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Generic Medicine Market Size Market Share by Type in 2022
Figure 10. Generic Medicine in CNS
Figure 11. Global Generic Medicine Market: CNS (2018-2023) & ($ Millions)
Figure 12. Generic Medicine in Cardiovascular
Figure 13. Global Generic Medicine Market: Cardiovascular (2018-2023) & ($ Millions)
Figure 14. Generic Medicine in Respiratory
Figure 15. Global Generic Medicine Market: Respiratory (2018-2023) & ($ Millions)
Figure 16. Generic Medicine in Rheumatology
Figure 17. Global Generic Medicine Market: Rheumatology (2018-2023) & ($ Millions)
Figure 18. Generic Medicine in Diabetes
Figure 19. Global Generic Medicine Market: Diabetes (2018-2023) & ($ Millions)
Figure 20. Generic Medicine in Oncology
Figure 21. Global Generic Medicine Market: Oncology (2018-2023) & ($ Millions)
Figure 22. Generic Medicine in Others
Figure 23. Global Generic Medicine Market: Others (2018-2023) & ($ Millions)
Figure 24. Global Generic Medicine Market Size Market Share by Application in 2022
Figure 25. Global Generic Medicine Revenue Market Share by Player in 2022
Figure 26. Global Generic Medicine Market Size Market Share by Regions (2018-2023)
Figure 27. Americas Generic Medicine Market Size 2018-2023 ($ Millions)
Figure 28. APAC Generic Medicine Market Size 2018-2023 ($ Millions)
Figure 29. Europe Generic Medicine Market Size 2018-2023 ($ Millions)
Figure 30. Middle East & Africa Generic Medicine Market Size 2018-2023 ($ Millions)
Figure 31. Americas Generic Medicine Value Market Share by Country in 2022
Figure 32. United States Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 33. Canada Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Mexico Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Brazil Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 36. APAC Generic Medicine Market Size Market Share by Region in 2022
Figure 37. APAC Generic Medicine Market Size Market Share by Type in 2022
Figure 38. APAC Generic Medicine Market Size Market Share by Application in 2022
Figure 39. China Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 40. Japan Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Korea Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Southeast Asia Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 43. India Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 44. Australia Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 45. Europe Generic Medicine Market Size Market Share by Country in 2022
Figure 46. Europe Generic Medicine Market Size Market Share by Type (2018-2023)
Figure 47. Europe Generic Medicine Market Size Market Share by Application (2018-2023)
Figure 48. Germany Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 49. France Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 50. UK Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Italy Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 52. Russia Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 53. Middle East & Africa Generic Medicine Market Size Market Share by Region (2018-2023)
Figure 54. Middle East & Africa Generic Medicine Market Size Market Share by Type (2018-2023)
Figure 55. Middle East & Africa Generic Medicine Market Size Market Share by Application (2018-2023)
Figure 56. Egypt Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 57. South Africa Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 58. Israel Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 59. Turkey Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 60. GCC Country Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 61. Americas Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 62. APAC Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 63. Europe Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Middle East & Africa Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 65. United States Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 66. Canada Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 67. Mexico Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Brazil Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 69. China Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 70. Japan Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 71. Korea Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 72. Southeast Asia Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 73. India Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 74. Australia Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 75. Germany Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 76. France Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 77. UK Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 78. Italy Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 79. Russia Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 80. Spain Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 81. Egypt Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 82. South Africa Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 83. Israel Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 84. Turkey Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 85. GCC Countries Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 86. Global Generic Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 87. Global Generic Medicine Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Generic Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Generic Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Generic Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Generic Medicine Sales Market Share by Country/Region (2022)
Figure 8. Generic Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Generic Medicine Market Size Market Share by Type in 2022
Figure 10. Generic Medicine in CNS
Figure 11. Global Generic Medicine Market: CNS (2018-2023) & ($ Millions)
Figure 12. Generic Medicine in Cardiovascular
Figure 13. Global Generic Medicine Market: Cardiovascular (2018-2023) & ($ Millions)
Figure 14. Generic Medicine in Respiratory
Figure 15. Global Generic Medicine Market: Respiratory (2018-2023) & ($ Millions)
Figure 16. Generic Medicine in Rheumatology
Figure 17. Global Generic Medicine Market: Rheumatology (2018-2023) & ($ Millions)
Figure 18. Generic Medicine in Diabetes
Figure 19. Global Generic Medicine Market: Diabetes (2018-2023) & ($ Millions)
Figure 20. Generic Medicine in Oncology
Figure 21. Global Generic Medicine Market: Oncology (2018-2023) & ($ Millions)
Figure 22. Generic Medicine in Others
Figure 23. Global Generic Medicine Market: Others (2018-2023) & ($ Millions)
Figure 24. Global Generic Medicine Market Size Market Share by Application in 2022
Figure 25. Global Generic Medicine Revenue Market Share by Player in 2022
Figure 26. Global Generic Medicine Market Size Market Share by Regions (2018-2023)
Figure 27. Americas Generic Medicine Market Size 2018-2023 ($ Millions)
Figure 28. APAC Generic Medicine Market Size 2018-2023 ($ Millions)
Figure 29. Europe Generic Medicine Market Size 2018-2023 ($ Millions)
Figure 30. Middle East & Africa Generic Medicine Market Size 2018-2023 ($ Millions)
Figure 31. Americas Generic Medicine Value Market Share by Country in 2022
Figure 32. United States Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 33. Canada Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Mexico Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Brazil Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 36. APAC Generic Medicine Market Size Market Share by Region in 2022
Figure 37. APAC Generic Medicine Market Size Market Share by Type in 2022
Figure 38. APAC Generic Medicine Market Size Market Share by Application in 2022
Figure 39. China Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 40. Japan Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 41. Korea Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 42. Southeast Asia Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 43. India Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 44. Australia Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 45. Europe Generic Medicine Market Size Market Share by Country in 2022
Figure 46. Europe Generic Medicine Market Size Market Share by Type (2018-2023)
Figure 47. Europe Generic Medicine Market Size Market Share by Application (2018-2023)
Figure 48. Germany Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 49. France Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 50. UK Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 51. Italy Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 52. Russia Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 53. Middle East & Africa Generic Medicine Market Size Market Share by Region (2018-2023)
Figure 54. Middle East & Africa Generic Medicine Market Size Market Share by Type (2018-2023)
Figure 55. Middle East & Africa Generic Medicine Market Size Market Share by Application (2018-2023)
Figure 56. Egypt Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 57. South Africa Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 58. Israel Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 59. Turkey Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 60. GCC Country Generic Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 61. Americas Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 62. APAC Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 63. Europe Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Middle East & Africa Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 65. United States Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 66. Canada Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 67. Mexico Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Brazil Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 69. China Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 70. Japan Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 71. Korea Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 72. Southeast Asia Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 73. India Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 74. Australia Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 75. Germany Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 76. France Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 77. UK Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 78. Italy Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 79. Russia Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 80. Spain Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 81. Egypt Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 82. South Africa Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 83. Israel Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 84. Turkey Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 85. GCC Countries Generic Medicine Market Size 2024-2029 ($ Millions)
Figure 86. Global Generic Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 87. Global Generic Medicine Market Size Market Share Forecast by Application (2024-2029)
